Renejix – Small Molecule CDMO (USA)
This document provides both a high-level overview of Renejix’s stand-alone small molecule analytical services, and a detailed list of services organized by functional area. Renejix’s stand-alone analytical services for small molecules operates out of the Industrial Park Happaugue, NY and Central, Islip, locations. Download to learn more.
FormaDose® Design Solution is a comprehensive drug design assessment consisting of a holistic review of the molecule, patient, and market considerations. Led…
If scientific literature indicates that elements are not likely to be present in drug product components, and no additional elements are added…
Quality by Design (QbD) is a well-known pharmaceutical industry strategy for enhancing production processes, including active pharmaceutical ingredients and medicinal products. Companies…
Characterizing an API’s different salt forms and polymorphs is an essential drug development task. The successful preclinical assessment and product development can…
A newly formed pharmaceutical company was creating a novel cardiometabolic drug, a new small molecule, that was in Phase 2a testing in…